
Fortress Biotech (FBIO) Earnings Dates & Reports
Fortress Biotech (FBIO) Most Recent Earnings
Report Date
Period EndingQ3 2025
Est. EPS-$0.55
Actual EPS$0.11
EarningsBeat
Fortress Biotech (FBIO) Earnings
View the latest Fortress Biotech (FBIO) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Fortress Biotech (FBIO)
Order type
Buy in
Order amount
Est. shares
0 shares
Fortress Biotech (FBIO) Earnings per Share (EPS) History
Signup for full accessBrowse free
Fortress Biotech (FBIO) Latest Earnings
The value each FBIO share was expected to gain vs. the value each share gained.
Fortress Biotech (FBIO) reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of $0.11. This exceeded analysts' expectations of -$0.55 by 120.00%, marking a Beat.
For comparison, Fortress Biotech reported EPS of -$0.76 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.08.
Fortress Biotech (FBIO) Earnings History
Fortress Biotech (FBIO) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Fortress Biotech’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Fortress Biotech (FBIO) Earnings FAQs
Fortress Biotech (FBIO) last reported earnings on Nov 12, 2025 for Q3 2025, posting an EPS of $0.11, which Beat the estimate of -$0.55 by 120.00%.
For Q3 2025, Fortress Biotech (FBIO) reported an EPS of $0.11, exceeding analysts' estimate of -$0.55 by 120.00%.
For Q3 2025, Fortress Biotech (FBIO) Beat expectations with an actual EPS of $0.11 vs. an estimated EPS of -$0.55.
Following the last earnings report on Nov 12, 2025, Fortress Biotech (FBIO)'s stock price moved — from — to —.
The next Fortress Biotech (FBIO) earnings call is scheduled for Mar. 30, 2026, where executives will discuss financial results and outlook.